Postmenopausal Disorder

4

Review clinical trials related to Postmenopausal Disorder. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Smart Technology-Based Intervention and Monitoring of Physical and Mental Health in Early Postmenopausal Women

The aim of this study is to compare the short-term and long-term effects of an 8-week home-based multimodal exercise program, delivered through a smartphone app, on quality of life, muscle function, and physical performance in early postmenopausal women.

Participants needed: 90
Trial details
Age: 40-65Biological sex: FemaleType: InterventionalSponsor: YI-JU TSAIUpdated: Apr 14, 2026Locations: 1
Eligibility criteria

45 to 65-year-old postmenopausal women [+2]

Exercised more than twice a week for at least 30 minutes per session [+6]

Status: Recruiting

Prevention of Recurrent UTI Using Vaginal Testosterone Versus Placebo Placebo

Women over the age of 60 years have an estimated 10 to 15 % risk of recurrent urinary tract infections (UTI). This is believed to be due to hormonally induced changes in the vaginal flora associated with menopause. After menopause, there is a chemical changes in the vagina that may predispose to bacterial infections. The role of vaginal estrogen creams to restore vaginal atrophy and prevent urinary tract infections has been well characterized. Vaginal testosterone (VT) application use in postmenopausal breast cancer patients on aromatase inhibitors have been shown to improve vaginal pH, vaginal atrophy symptom scores, dyspareunia, and vaginal dryness. Although testosterone has been used to improve sexual function in postmenopausal women, the effects of VT on vaginal flora and recurrent UTIs are unknown. The purpose of this study is to determine whether topically applied vaginal testosterone cream is more effective than placebo in reducing the incidence of urinary tract infections in postmenopausal women with recurrent urinary tract infections and to ascertain the effects of topical estrogen on the vaginal pH and flora.

Participants needed: 100
Trial details
Phase: Phase 4Age: 60-90Biological sex: FemaleType: InterventionalSponsor: Maimonides Medical CenterUpdated: Nov 5, 2025Locations: 1
Eligibility criteria

60-90 yo Female [+7]

Current UTI/ Dipstick and culture positive (> trace leukocytes or nitrites) [+8]

Status: Recruiting

The MUSE Study for Menopausal Arthralgia

The investigators plan to conduct a pilot 4-arm, randomized study comprising the following interventions: muscle strengthening exercises (MSE) alone, estrogen therapy (ET) alone, and a combination of MSE and ET, compared to usual care in women with menopausal arthralgia. The aim of this pilot study is to assess the feasibility, patient acceptability, and patient perspectives and logistics of delivering interventions, and practicability of outcome assessment tools in this 4-arm study over a 12-week period.

Participants needed: 100
Trial details
Phase: Phase 2, Phase 3Age: 30-59Biological sex: FemaleType: InterventionalSponsor: National University Hospital, SingaporeUpdated: Jul 31, 2024Locations: 1
Eligibility criteria

Patients with muscle stiffness and joint discomfort in various sites, including... [+4]

History of thrombo-embolic diseases, strokes, ischemic heart disease, dementia o... [+15]

Status: Recruiting

Inspiratory Muscle Training X CardioBreath App Effects On Vagal Modulation And Pulse Wave Velocity

Existing data points to relevant beneficial effects of respiratory exercises on cardiovascular health, with special regards to decreases on arterial pressure and improves on autonomic and vascular profiles, though mechanistics of such results have not yet been cleared. Among the available ways to perform respiratory exercises, there is the highly recommended Inspiratory Muscle Training (IMT) and slow breathing exercises like Yoga pranayamas. Lately, the development of new technologies has allowed the use of Apps to perform respiratory exercises. This study will be take the just developed CardioBreath®App to validate it as a tool to perform respiratory exercises. Therefore, it will be compared to IMT on cardiac vagal modulation and pulse wave velocity on normotensive post menopause women.

Participants needed: 24
Trial details
Age: 45-65Biological sex: FemaleType: InterventionalSponsor: Instituto de Cardiologia do Rio Grande do SulUpdated: Jun 21, 2024Locations: 1
Eligibility criteria

Follicle Stimulating Hormone (FSH)>35mui/ml [+2]

Hypertension [+8]